Anaplasma Species Differentiation via Purified Polypeptide Antigens
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current serologic tests for Anaplasma cannot differentiate between Anaplasma phagocytophilum and Anaplasma platys infections due to significant cross-reactivity, and there is a need for a rapid, sensitive, and reliable immunological test for detecting acute Anaplasma infections in mammals exhibiting clinical symptoms.
Innovation Solution
Development of compositions comprising purified polypeptides with specific antigenic determinants recognized by antibodies specific for Anaplasma phagocytophilum or Anaplasma platys, along with methods for detecting these antibodies and polypeptides, including the use of indicator reagents and signal sequences to enhance detection sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current serologic tests are used to detect Anaplasma infections, then the detection process is simple and rapid, but the tests cannot differentiate between Anaplasma phagocytophilum and Anaplasma platys due to significant cross-reactivity
Solution Approach 1:
The patent divides the detection system into separate components: one test composition specifically detects antibodies against Anaplasma phagocytophilum using its unique polypeptide antigens, while another composition detects antibodies against Anaplasma platys using its distinct polypeptide antigens. This segmentation eliminates cross-reactivity by ensuring each test targets species-specific antigens only.
Solution Approach 2:
The patent applies local quality by selecting and using specific polypeptide antigens from each Anaplasma species that are uniquely recognized by antibodies against that species. The test compositions are tailored with locally optimized antigen selections (species-specific polypeptides) rather than using general Anaplasma antigens, thereby achieving high differentiation accuracy.
2Measurement precision
If specific polypeptide antigens are used to differentiate Anaplasma species, then measurement precision improves, but the complexity of the test composition increases
Solution Approach 1:
The patent extracts and isolates specific polypeptide antigens from each Anaplasma species that are responsible for species-specific antibody recognition. By taking out only the essential diagnostic polypeptides (and their coding sequences) rather than using whole organisms or complex antigen mixtures, the test achieves high precision while maintaining manageable composition complexity.
3Speed
If rapid detection methods are used for acute Anaplasma infections, then the speed of diagnosis improves, but the sensitivity and reliability of the test may be compromised due to early infection stage
Solution Approach 1:
The patent prepares test compositions in advance with optimized species-specific polypeptide antigens and appropriate controls, enabling immediate testing when clinical symptoms appear. The preliminary preparation of highly specific test reagents ensures that even in the early acute phase when antibody levels may be low, the test can rapidly and reliably detect the presence of species-specific antibodies without compromising accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described compositions and methods enable effective differentiation between Anaplasma phagocytophilum and Anaplasma platys infections, providing a rapid and reliable diagnostic tool for detecting antibodies and polypeptides, thereby facilitating accurate diagnosis and treatment.
Implementation Method 1
compositions comprising polypeptides comprising antigenic determinants that are recognized by antibodies that are specific for Anaplasma platys or Anaplasma phagocytophilum
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
The invention provides methods and compositions for the detection and treatment of Anaplasma phagocytophilum and Anaplasma platys infection.